WO2025072425A3 - Chimères ciblant les sheddases pour la modulation de la protéostase - Google Patents

Chimères ciblant les sheddases pour la modulation de la protéostase Download PDF

Info

Publication number
WO2025072425A3
WO2025072425A3 PCT/US2024/048537 US2024048537W WO2025072425A3 WO 2025072425 A3 WO2025072425 A3 WO 2025072425A3 US 2024048537 W US2024048537 W US 2024048537W WO 2025072425 A3 WO2025072425 A3 WO 2025072425A3
Authority
WO
WIPO (PCT)
Prior art keywords
sheddase
fusion molecules
integral membrane
targeting
sheddases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/048537
Other languages
English (en)
Other versions
WO2025072425A2 (fr
Inventor
Brett Garabedian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of WO2025072425A2 publication Critical patent/WO2025072425A2/fr
Publication of WO2025072425A3 publication Critical patent/WO2025072425A3/fr
Anticipated expiration legal-status Critical
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/626—Diabody or triabody

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des molécules de fusion pour induire la proximité entre des protéines membranaires intégrales et des protéases membranaires intégrales (sheddases), favorisant ainsi la protéolyse ciblée (changement) de l'ectodomaine de protéine membranaire cible. Ces molécules de fusion, chimères ciblant les sheddases (SHEDTAC), contiennent un domaine de ciblage de protéase et un domaine de ciblage de substrat qui se lient respectivement à une sheddase et à une protéine cible d'intérêt (par exemple, un récepteur de surface cellulaire). L'invention concerne également des polynucléotides codant pour les molécules de fusion, des vecteurs d'expression associés et des cellules hôtes, ainsi que des procédés utilisant les molécules de fusion pour accélérer la protéolyse de membrane intégrale par des sheddases locales.
PCT/US2024/048537 2023-09-26 2024-09-26 Chimères ciblant les sheddases pour la modulation de la protéostase Pending WO2025072425A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363585233P 2023-09-26 2023-09-26
US63/585,233 2023-09-26

Publications (2)

Publication Number Publication Date
WO2025072425A2 WO2025072425A2 (fr) 2025-04-03
WO2025072425A3 true WO2025072425A3 (fr) 2025-05-01

Family

ID=95201327

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/048537 Pending WO2025072425A2 (fr) 2023-09-26 2024-09-26 Chimères ciblant les sheddases pour la modulation de la protéostase

Country Status (1)

Country Link
WO (1) WO2025072425A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074840A2 (fr) * 2006-12-19 2008-06-26 Ablynx N.V. Séquences d'acides aminés dirigées contre une métalloprotéinase de la famille adam et polypeptides les comprenant à des fins de traitement de maladies et troubles liés à adam
WO2019179365A1 (fr) * 2018-03-20 2019-09-26 WuXi Biologics Ireland Limited Nouveau polypeptide anticorps anti-lag-3

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074840A2 (fr) * 2006-12-19 2008-06-26 Ablynx N.V. Séquences d'acides aminés dirigées contre une métalloprotéinase de la famille adam et polypeptides les comprenant à des fins de traitement de maladies et troubles liés à adam
WO2019179365A1 (fr) * 2018-03-20 2019-09-26 WuXi Biologics Ireland Limited Nouveau polypeptide anticorps anti-lag-3

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JIA YITING, KONG WEI: "ADAM17 : A Molecular Switch to Control TNFR2 During Atherogenesis In Vivo", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, LIPPINCOTT, WILLIAMS & WILKINS, vol. 37, no. 2, 1 February 2017 (2017-02-01), pages 176 - 178, XP093312945, ISSN: 1079-5642, DOI: 10.1161/ATVBAHA.116.308840 *

Also Published As

Publication number Publication date
WO2025072425A2 (fr) 2025-04-03

Similar Documents

Publication Publication Date Title
MX2025009543A (es) Variantes fc con union mejorada a fcrn y semivida prolongada
DE602006019050D1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
ES2379283T3 (es) Proteínas de unión a albúmina sérica
WO2008114149A3 (fr) Antigènes chimériques
DE602005016712D1 (de) Rter dna
WO2006042158A3 (fr) Procedes et compositions permettant d'ameliorer la production de proteines recombinees
ATE512980T1 (de) Polypeptide mit beta-glucosidase-aktivität sowie diese codierende polynukleotide
DK1641818T3 (da) Polypeptider der har bindingsaffinitet for HER2
ATE503009T1 (de) Polypeptide mit lipase-aktivität und diese kodierende polynukleotide
BRPI0618449A2 (pt) métodos para produção de isoformas de receptor e ligante
ATE541283T1 (de) Verfahren zum mischen von farben in einem display
NO20073288L (no) Gram-positive rekombinant protein-produserende bakterier
MX2009012326A (es) Peptidos de señalizacion.
ATE515568T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
WO2007018619A3 (fr) Agents therapeutiques chimeriques
MX2025013732A (es) Anticuerpos de dominio unico modificados
NO20072966L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse
NZ589806A (en) Variant hedgehog-interacting protein (hhip1) and methods and uses thereof
PH12017502080A1 (en) Epidermal growth factor receptor variant iii-mesothelin fusions and methods of using the same
WO2025072425A3 (fr) Chimères ciblant les sheddases pour la modulation de la protéostase
ATE320485T1 (de) Mutierte furin polypeptide, welche verbesserte eigenschaften aufweisen
WO2005001099A3 (fr) Systeme d'expression de proteine
GB201102700D0 (en) Protein secretion
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24873539

Country of ref document: EP

Kind code of ref document: A2